Products

FDA Approved Linezolid 165800-03-3

China FDA Approved Linezolid 165800-03-3, Find details about China Linezolid Powder, Bacterial Protein Synthesis Inhibitors from FDA Approved Linezolid 165800-03-3

Model NO.
Linezolid
Product Name
Linezolid Powder
Botanical Name
Linezolid Powder
Active Ingredient
Linezolid
Appearance
White Powder
Test Method
HPLC
Molecular Formula
C38h72n2o12
Use
Antibiotic and Antimicrobial Agent
Grade
Phamaceutical Grade
Function
Anti-Allergic Agents
CAS No
165800-03-3
Storage
Store in a Cool and Dry Place
Free Sample
10 Grams Available
Apply
Pharmaceutical Intermediates
Solubility
Soluble in Acetone, Very Slightly Soluble in Hot
Shipment
by FedEx DHL
Trademark
Zebrago
Transport Package
Drum
Specification
99% Min
Origin
China
HS Code
2932999099
Model NO.
Linezolid
Product Name
Linezolid Powder
Botanical Name
Linezolid Powder
Active Ingredient
Linezolid
Appearance
White Powder
Test Method
HPLC
Molecular Formula
C38h72n2o12
Use
Antibiotic and Antimicrobial Agent
Grade
Phamaceutical Grade
Function
Anti-Allergic Agents
CAS No
165800-03-3
Storage
Store in a Cool and Dry Place
Free Sample
10 Grams Available
Apply
Pharmaceutical Intermediates
Solubility
Soluble in Acetone, Very Slightly Soluble in Hot
Shipment
by FedEx DHL
Trademark
Zebrago
Transport Package
Drum
Specification
99% Min
Origin
China
HS Code
2932999099

FDA Approved Linezolid 165800-03-3
Product NameLinezolid powder
Part UsedLinezolid powder
AppearanceWhit Powder
Active IngredientLinezolid powder
Specification99%

Linezolid is supplied as a ready-to-use sterile isotonic solution for intravenous infusion. Each mL contains 2 mg of linezolid. Inactive ingredients are sodium citrate, citric acid, and dextrose in an aqueous vehicle for intravenous administration. The sodium (Na+) content is 0.38 mg/mL (5 mEq per 300-mL bag; 3.3 mEq per 200-mL bag; and 1.7 mEq per 100-mL bag).


FDA Approved Linezolid 165800-03-3

For the treatment of infections caused by Gram-positive cocci, the complex infections of skin and soft tissue, uncomplicated infections of skin and soft tissue, treatment ofinfections caused by vancomycin-resistant Enterococcus faecium. 

FDA Approved Linezolid 165800-03-3

Certificate of Analysis

Batch NumberZ20190412001
Production Date2019.04.12
Batch Quantity80 KGS
 ItemTest StandardTesting Result
AppearancePowder Complies
ColorWhite fine PowderComplies
Particle Size100% pass 80 meshComplies
OderCharacteristicComplies
TasteCharacteristicComplies
Loss on Drying≤5.0%2.20%
Residue on Ignition≤0.1%0.05%
Residual acetone≤0.1%Complies
Residual Ethanol≤0.5%Complies
Heave Mentals≤10ppmComplies
Na≤0.1%<0.1%
Pb≤3 ppmComplies
Total Plate<1000CFU/gComplies
Yeast & Mold<100 CFU /gComplies
E. ColiNegative Complies
SalmonellaNegativeComplies
Conclusion: Conform with USP Standard

Storage:Closed container. dry & cool. keep away from moisture &strong light
Shelf life:24 Months  


FDA Approved Linezolid 165800-03-3


FDA Approved Linezolid 165800-03-3
 


FDA Approved Linezolid 165800-03-3

Shipping Options as follows
 

EMSAround 7-10 working days
DHLAround 3-5 working days
FedexAround 4-6 working days
TNTAround 6-7 working days
By AirAround 5-7 working days
By SeaAround 15-30 working days

     


FDA Approved Linezolid 165800-03-3

Perfect After-Sales Service

  1. Product Pictures Showing
  2. Shipment Tracking Number
  3. Promptly Following Tracking Status
  4. Delivery Notice
  5. Product Quality Following
  6. Product Feedback
  7. Follow-up Improvement Suggestion


FDA Approved Linezolid 165800-03-3


FDA Approved Linezolid 165800-03-3


FDA Approved Linezolid 165800-03-3


FDA Approved Linezolid 165800-03-3
FAQ

FDA Approved Linezolid 165800-03-3
 

You Might Also Like